Invention Grant
US09580419B2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
有权
吡咯并[2,3-b]吡啶-4-基胺和吡咯并[2,3-b]嘧啶-5-基胺作为Janus激酶抑制剂
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors](/docs/US/2017-02-28/US09580419B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
- Patent Title (中): 吡咯并[2,3-b]吡啶-4-基胺和吡咯并[2,3-b]嘧啶-5-基胺作为Janus激酶抑制剂
-
Application No.: US14799777Application Date: 2015-07-15
-
Publication No.: US09580419B2Publication Date: 2017-02-28
- Inventor: James D. Rodgers , Haisheng Wang , Andrew P. Combs , Richard B. Sparks
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/10 ; A61K31/437 ; C07D471/04 ; C07D487/04
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors](/abs-image/US/2017/02/28/US09580419B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
Public/Granted literature
- US20150315185A1 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS Public/Granted day:2015-11-05
Information query
